-       Report 
   - April 2025
    -  200 Pages 
    Global
   
   From       €4036EUR$4,490USD£3,539GBP 
                  -       Report 
   - September 2025
    -  150 Pages 
    Global
   
   From       €4000EUR$4,450USD£3,508GBP 
                  -       Report 
   - July 2024
    -  150 Pages 
    Global
   
   From       €2696EUR$3,000USD£2,365GBP 
      €3371EUR$3,750USD£2,956GBP 
                  -       Report 
   - July 2024
    -  100 Pages 
    Global
   
   From       €2696EUR$3,000USD£2,365GBP 
      €3371EUR$3,750USD£2,956GBP 
                -       Report 
   - October 2023
    -  145 Pages 
    Global
   
   From       €2831EUR$3,150USD£2,483GBP 
                 -       Report 
   - September 2024
    -  54 Pages 
    Global
   
   From       €2247EUR$2,500USD£1,971GBP 
                -       Report 
   - June 2023
    -  1041 Pages 
    Europe
   
   From       €8085EUR$8,995USD£7,090GBP 
                      Within the field of medical devices, the abdominal stent graft market is a specialized category that pertains to the treatment of abdominal aortic aneurysms (AAA). A stent graft is a tubular device composed of fabric supported by a metal mesh called a stent. It is used to reinforce weakened sections of an artery. Contrary to vascular stents, which are used to prop open arteries that have been narrowed by plaque, stent grafts are specifically designed to prevent the rupture of aneurysms by    redirecting blood flow away from the weakened and bulging section of the vessel wall. This minimally invasive procedure is known as endovascular aneurysm repair (EVAR). The market is driven by technological advancements in stent graft designs, an aging population more prone to cardiovascular diseases, and a preference for minimally invasive surgeries over open surgical methods. The different types of abdominal stent grafts include bifurcated and aorto-uni-iliac systems, depending on the anatomy and needs of the patient.
Some leading companies in the abdominal stent graft market are Medtronic, Cook Medical, and W. L. Gore & Associates. These companies are established players and offer a range of endovascular grafts for abdominal and thoracic aortic aneurysm repair. Other competitors in the market include Endologix, Terumo Corporation, and Lombard Medical, each contributing to the technological enhancements and broadening the portfolio of stent Show Less   Read more